Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-05-04 Sale | 2020-05-06 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 272 | $11.51 | $3,131 | 197,658 (Direct) | View |
| 2020-04-15 Sale | 2020-04-20 06:07 am | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 53,618 | $4.88 | $261,656 | 2,804,336 (Direct) | View |
| 2020-04-01 Sale | 2020-04-03 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 11,524 | $4.79 | $55,200 | 282,878 (Direct) | View |
| 2020-03-16 Sale | 2020-03-20 9:30 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 2,849 | $3.88 | $11,054 | 316,885 (Direct) | View |
| 2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 26,191 | $4.9716 | $130,211 | 771,764 (Direct) | View |
| 2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 1,266 | $5 | $6,330 | 197,930 (Direct) | View |
| 2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 57,451 | $4.9819 | $286,213 | 2,857,954 (Direct) | View |
| 2020-03-09 Sale | 2020-03-13 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 13,857 | $4.9779 | $68,978 | 319,734 (Direct) | View |
| 2020-02-25 Sale | 2020-02-28 9:32 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 9,147 | $6.43 | $58,815 | 333,591 (Direct) | View |
| 2020-02-25 Sale | 2020-02-28 9:32 pm | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 24,642 | $6.42 | $158,202 | 2,915,405 (Direct) | View |
| 2020-02-25 Sale | 2020-02-28 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 11,547 | $6.42 | $74,132 | 797,955 (Direct) | View |
| 2020-02-07 Sale | 2020-02-14 9:29 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 5,064 | $6.72 | $34,030 | 199,196 (Direct) | View |
| 2020-01-22 Sale | 2020-01-24 9:31 pm | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 22,139 | $7.02 | $155,416 | 601,085 (Direct) | View |
| 2020-01-08 Sale | 2020-01-10 9:16 pm | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 13,228 | $10.37 | $137,174 | 623,224 (Direct) | View |
| 2019-12-23 Sale | 2020-01-03 5:19 pm | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 46,312 | $10.84 | $501,959 | 636,452 (Direct) | View |
| 2019-12-23 Sale | 2020-01-03 5:18 pm | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 4,517 | $10.84 | $48,958 | 235,421 (Direct) | View |
| 2019-12-23 Sale | 2020-01-03 5:18 pm | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 56,028 | $10.84 | $607,267 | 2,514,773 (Direct) | View |
| 2019-12-23 Sale | 2020-01-03 5:17 pm | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 2,670 | $10.84 | $28,939 | 98,321 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-06-10 Disposition | 2020-06-10 11:22 am | N/A 2026-02-24 | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 45,102 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:22 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 327,878 | $0 | 0 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-10 11:22 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 45,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:22 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Sard Mark Director | 51,468 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:21 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | HUME DANIEL Director | 35,468 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:20 am | N/A 2021-03-08 | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 627,756 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:20 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 3,024,336 | $0 | 0 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-10 11:20 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 220,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:19 am | N/A 2021-03-08 | STEMLINE THERAPEUTICS INC | STML | BENTSUR RON Director | 85,104 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:19 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | BENTSUR RON Director | 66,346 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:18 am | N/A 2026-01-07 | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 69,058 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:18 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 1,374,352 | $0 | 0 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-10 11:18 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 600,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:17 am | N/A 2026-09-19 | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 50,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:17 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 200,891 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:15 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Cline Darren S Director | 35,468 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:12 am | N/A 2026-05-25 | STEMLINE THERAPEUTICS INC | STML | Forman Alan S Director | 58,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:12 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Forman Alan S Director | 88,298 | $0 | 0 (Direct) | View |
| 2020-06-10 Disposition | 2020-06-10 11:11 am | N/A 2026-05-25 | STEMLINE THERAPEUTICS INC | STML | ZUERBLIS KENNETH J Director | 58,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Equity Swap | 2020-06-10 11:11 am | N/A N/A | STEMLINE THERAPEUTICS INC | STML | ZUERBLIS KENNETH J Director | 60,121 | $0 | 0 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-14 9:29 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer | 208,417 | $0 | 809,502 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-14 9:29 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Francomano Robert Chief Commercial Officer | 105,939 | $0 | 199,196 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-14 9:28 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Gionco David Chief Accounting Officer | 107,317 | $0 | 342,738 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-14 9:28 pm | N/A N/A | STEMLINE THERAPEUTICS INC | STML | Bergstein Ivan Chief Executive Officer | 425,274 | $0 | 2,940,047 (Direct) | View |